~01.3,
THROMBOSIS RESEARCH Printed in the United
DEMONSTRATION
PP* Pergamon
States
OF PLATELET FIBRINOGEN SECRETION CONNECTING SYSTEM
347-356,
1973 Inc.
Press,
VIA THE SURFACE
Jan J. Sixma*, Erik H. Mijrer and Torstein
Randi Holme,
Hovig
Electron Microscopic Laboratory, Institute of Pathology and Institute for Thrombosis R.esearch. Rikshospitalet, Oslo, Norway 14.5.1973;
in revised form 26.7.1973. Accepted by Editor J. Hugues)
(Received
Fibrin fibres were observed in the surface connecting system (SCS) in washed human platelets treated with Platelets preincubated thrombin (5 NIH units/ml). with iodoacetic acid (2 mMl and antimycin (250 ng/mll, in order to prevent the release reaction, showed no fibrin in the SCS after addition-of thrombin. These data exclude the possibility that the fibrin is formed from retained plasma fibri,nogen and indicate that platelet fibrinogen is secreted via the SCS.
ABSTRACT
Introduction Platelets tion"
respond to various
(1,2,3l, which
depending
on the strength
ristics of a secretion (3).
possibly
platelet
factor 4 (3,4,5,6)
nogen and acid hydrolases adrenaline tiated
by
and serotonin. thrombin,
and is associated
calcium,
collagen
(71. Both or
and
It has many characte-
have been discerned:
serotonin,
reac-
energy requiring,
of the stimulus.
process
Two types of release
adenine nucleotides,
stimuli with a "release
is highly selective,
with degranulation Release
I involving
glycosaminoglycans
and release
and
II involving
Release
I is induced by AOP,
release
I
latex
particles.
*On leave of absence. Div. of Haemostasis, Hosp., Utrecht, The Netherlands, 347
and
II
together
Evidence
is
fibriini-
has
Dept. of Med., Univ.
PLATELET
348
accumulated storage
indicating
organelles
acid hydrolases a-granules
FIBRINOGEN
that the dense granules
and fibrinogen
(7,81, whereas
to be located
in the
(9,101.
extrusion
morphological process
are thought
Vo1.3,No.3
are the main
for ADP, ATP and serotonin
Only very few electron showing
SECRETION
of material
evidence
have been published
from the platelet.
This lack of
may be due to the fact that the secretion
is very rapid.
Based on observations
dense tracers
as markers
White
has suggested
(10,111
micrographs
for the surface
using electron
connecting
that secretion
system
(SCSI,
may take place via
the SCS. In the present platelet
fibrinogen
paper evidence is secreted
we have made use of the chance subjected
to relatively
fibrin fibres within
is presented
in this way. observation
high thrombin
indicating
To attain
that washed
concentrations
that
this platelets
contain
their SCS.
Materials
and Methods
Antimycin, A was from Nutritional
Biochemicals
Corporation,
Cleve-
land, Ohio. EOTA, ethylenediaminetetraacetic 1111, was from E. Merck,
acid disodium
Oarmstadt,
Germany.
Iodoacetic
acid was from The British
Thrombin.
Bovine thrombin
LaRoche,
easel,
Preparation obtained
Drug Houses
Topostasine
Ltd., England.
"Roche" was from Hoffmann-
Switzerland.
of suspensions
from voluntary
used as anticoagulant Platelet
salt (Titriplex
of washed
Blood was
platelets.
donors who had used no drugs, EOTA was (2 ml O.lM EOTA,
rich plasma was obtained
pH 7.4, to 40 ml blood).
by centrifugation The platelets
(15 min at
were
isolated
room temperature,
gmax = 300 xgl.
by centrifugation
at gmax = 900 xg for 20 min at 4'C and twice
washed
by resuspending
(0.135 M NaCl, The platelet Control
0.012 M Tris-HCl,
button was finally
platelets
The platelet
the platelet
and platelets
suspensions
bolic incubator.
button
0.0015
in 25 ml buffer A
M EDTAI,
resuspended
pH .7.65, at 4'C.
in 8 ml buffer A.
treated with metabolic
inhibitors.
were shaken at 37'C in a Oubnoff
Eight hundred
~1 of platelet
suspensions
metawere
PLATELET
Vo1.3,No.3
either
incubated
solution
FIBRINOGEN
with 100 ~1 of buffer A only or 100 ~1 of a
of iodoacetic
acid in buffer A (final concentration
2 mN) and 5 ~1 of a solution concentration
250 ng/ml)
of antimycin
Thrombin
(in 96% ethanol,
final
Hundred ul of buffer
for 30 min (a).
A were then added and the incubation suspension
3-49
SECRETION
was stopped
by adding the
to glutaraldehyde.
treated
platelets
with and without
Eight hundred ul of platelet Hundred
(a) above. concentration was stopped
suspensions
ul of a thrombin
5 NIH units/ml)
metabolic
were
inhibitors.
incubated
solution
as in
in buffer A (final
were then added.
The incubation
after 1 min or 10 min by adding the incubation
mix-
ture to glutaraldehyde. Clotting
The possible
studies.
of platelet
of iodoacetic
250 ng/ml, on fibrin formation
2 mN, and antimycin, in a separate
influence
experiment:
No prolongation
poor plasma was observed
acid,
was studied
of the clotting
after 30 minutes
times
incubation
with these substances. Electron microscopy.
The platelet
9 ml 2.5% glutaraldehyde
in 0.1 N Sarensen's
pH 7.2, at room temperature mented
to a button, washed
postfixed
through
for 15 hr.
of graded
in Tyrode's
out at room temperature,
finally
in Epon 812.
with uranyl acetate Elmiskop
Ultrathin
and lead citrate,
buffer, were sedi-
buffer for 1 hr.
buffer
ethanol solutions,
dure was carried embedded
phosphate
in
buffer, 'pH 7.2, and
was then washed with Tyrode's
a series
were fixed
The platelets
with Tyrode's
in 1% osmium tetroxide
The specimen
suspensions
and dehydrated
The whole
The specimen sections
and examined
procewas
were stained in a Siemens
I electron microscope,
Results Control
platelets
that had been incubated
only, contained a-granules and dense bodies, and dilated SCS which occasionally contained material,
but was usually
Thrombin
treated
The SCS was markedly tron dense material,
empty
platelets
dilated
with buffer A
and showed
pseudopods
some amorphous
(Fig. 1). were nearly all degranulated.
and was filled with amorphous,
In many vacuoles
fibres were observed,
elec-
PLATELET
350
FIBRINOGEN
SECRETION
Vo1.3,No.3
FIG. 1 Control platelets. a-granules (GRl, dense bodies [DE!), mitochondria (MIT), glycogen (GLYl, vacuoles (SCSI.
occasionally 200-230
showing
a cross striation
A, characteristic
rence was found between minutes
the samples
(Figs. 2,3,41. incubated
of
No diffe-
for 1 or 10
with thrombin.
Platelets had a rounded, similar
for fibrin
with a periodicity
incubated swollen
iodoacetic
appearance
to the description
with monoiodoacetate
with
without
of Behnke
and potassium
acid and antimycin dilatation
of the SCS
(121 of platelets
cyanide.
treated
Vo1.3,No.3
PLATELET
FIBRINOGEN
SECRETION
FIG. 2 Platelets incubated for 10 min with thrombin. Nearly all the a-granules and dense bodies have been released. The SCS is filled with amorphous material (AM). agranules (GR), dense bodies (081, mitochondria (MIT), glycogen (GLY).
352
PLATELET
FIBRINOGEN
SECRETION
Vo1.3,No.3
FIG. 3 The same preparation as in Fig. 2 shown at a higher magnification. Fibrin fibres (FIB1 are seen in the SCS. Nitochondria (NIT), glycogen (GLYI.
Platelets incubated with thrombin for 1 or 10 minutes after preincubation with iodoacetic acid and antimycin had a swollen appearance, but no evident degranulation was observed and the SCS was empty as a rule (Fig. 5). -The platelets showed no difference from the platelets incubated with only iodoacetic acid and antimycin.
Discussion The material present in the SCS of thrombin treated platelets has the appearance of fibrin as demonstrated by the presence of the characteristic cross striation. This cross striation was,
Vo1.3,No.3
PLATELET
FIBRINOGEN
SECRETION
FIG. 4 Platelets from a suspension treated with thrombin for 10 seconds, cooled quickly in an ice-bath and prepared The specimen was embedded in Araldite further at 4’C. A fibrin fibre and sections stained with lead citrate. (FIB) with a periodicity of about 230 A is located in the SCS. Mitochondria (MIT), p;lycoEen (GLY).
353
PLATELET
354
FIBRINOGEN
FIG.
SECRETION
Vo1.3.No.3
5
Platelets preincubated with iodoacetic acid and antimycin for 30 min and treated with thrombin for 10 min. Slight swelling; preservation of the organelles similar in the control platelets. u-granules (GR1, (WIT), glycogen (GLY 1, (DB), mitochondria
however, in
the
often
absent,
an
observation
frequently
in platelet
canaliculi
commented
upon
literature. Fibrin
formation
demonstrated
by Droller
as releasing
agents.
fibrinogen
retained
has also been
(131 with both thrombin
This
fibrin
might
be
formed
in the SCS during washing
and collagen from
plasma
or from platelet
PLATELET
Vo1.3.No.3
fibrinogen
released
by the action
bility seems unlikely most canaliculi
ferritin
of
SECRETION
on the membrane
labelled
former
of material
possiin
This view is further
in washed platelets. of Sixma
355
The
thrombin.
in view of the scarcity
ted by the observations fibrinogen
FIBRINOGEN
suppora
(141 who found no detectable
surface
of washed
platelets
Complete
antifibrinogen.
proof,
utilizing
however,
has
not yet been obtained, The experimental conditions
under which thrombin
rin was detectable originate
set up described
iodoacetic
observed
plasma fibrinogen. after incubation
acid and antimycin
not shown).
The complete
tron micrographs
absence
of platelets
plasma fibrin.
presented a-granules
with a combination with thrombin
of fibrin
originate
Day and Solum
release of (data
in the SCS in elec-
thus treated shows that the fibrin
treatment
from retained
If fib-
it could
Negligible
and treatment
observed after thrombin
fibrinogen
cause no release.
in the SCS under these conditions,
from retained
was, however,
would
in this paper offered
of washed
platelets
does not
(151 have shown that part of the platelet
was localized
in low density
in this paper demonstrate
a-granules.
that the release
The data from the
is via the SCS.
Acknowledgements The authors express Anatomical
Institute,
for many helpful Society
their gratitude
University
suggestions.
- Landsforeningen
to dr. B. Reino Olsen,
of Oslo, and dr. H. Holmsen,
Supported
by the Norwegian
mot Kreft, by the Netherlands
Organi-
zation for the Advancement
of Pure Scientific
Norwegian
for Science and the Humanities.
Research
Council
Research
Cancer
and the
References 1.
GRETTE, K. Studies on the mechanism of thrombin-catalyzed hemostatic reactions in blood platelets, Acta physiol. stand.: 56 (suppl. 1951, 83, 1962.
356
PLATELET
FIBRINOGEN
SECRETION
Vo1.3,No.3
2.
substance HOVIG, T. Release of a platelet-aggregating (adenosine diphosphatel from rabbit blood platelets induced by saline "extract" of tendons. Thrombos. Oiathes. haemorrh. (Stuttg.1: 2, 264, 1963.
3.
HOLMSEN, H., DAY, H.J. and STORMORKEN, H. The blood platelet release reaction, Stand. J. Haemat.: Suppl. 8, 1969.
4.
STORMORKEN, H. The release Haemat.: Suppl. 2, 1969.
5.
HAGEN, I. The release of glycosaminoglycans during exposure of human platelets to thrombin and polystyrene latex partiBiochim. hiophys. Acta: 273, 141, 1972. cles.
6.
MURER, E.H. and HOLME, R. A Study of the release of calcium from human blood platelets and its inhibition bv metabolic Biochim. biophys. inhibitors, N-ethylmaleimide and aspirin. Acta: 222, 197, 1970. --
7.
DAY, H.J. and HOLMSEN, H. Concepts of the blood platelet release reaction, Ser. Haematol.: 4, 1, 1971.
6.
DA PRAOA, M., PLETSCHER, Subcellular localization mine in blood platelets,
9.
HOLMSEN, reaction 1966.
reaction
of secretion.
Stand.
J.
A., TRANZER, J.P. and KNLICHEL, H. of 5-hydroxytryptamine and histaNature (Lond.1: 216, 1315, 1967.
H. and DAY, H.J. Thrombin-induced platelet release and platelet lysosomes. Nature ILond.1: 219, 76.0,
10.
WHITE, J.G. A search for the platelet secretory pathway 31, 1970. using electron dense tracers. Amer. J. Path.: 2,
11.
Oegranulation WHITE, J.G. Path .: 68, 289, 1972.
12.
BEHNKE, 0. Effect of some chemicals on blood platelet platelet shape and some platelet functions microtubules, vitro. Stand. J. Haemat,: L, 123, 1970.
of discoid
platelets.
Amer.
J.
in
13.
DROLLER, M.J. Ultrastructural changes associated with Abstr. Proc. platelet nucleotide and calcium release. 1972. Ann. Meet. Amer. Sot. Clin. Invest., Atlantic City J. clin. Invest.: 51, 25a. 1972.
14.
SIXMA, J.J. and MOLENAAR, I. An ultrastructural study of Thrombos. adherent material to the human platelet membrane. Oiathes. haemorrh. (Stuttg.1: Suppl. 2, 21, 1967.
15.
Fibrinogen associated with subDAY, H;J. and SOLUM, N.O. cellular platelet particles. Stand. J. Haemat. In press ,1973.